Combined model-based and patient-specific dosimetry for risk evaluation of 18F-DCFPyL, a PSMA-targeted PET agent for patients with metastatic prostate cancer (PCa)
Year: 2015
Type: article
Source: Journal of Nuclear Medicine
Institution: Johns Hopkins University
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2504869397
